Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Spandana Brown"'
Publikováno v:
Clinical Thyroidology. 32:39-42
Autor:
Daniel L. Riconda, Feibi Zheng, Spandana Brown, Liye Suo, Richard J. Robbins, Gilchrist L Jackson
Publikováno v:
Journal of the Endocrine Society
The coexistence of multiple endocrine neoplasia type 1 (MEN1) and type 2A (MEN2A) is a rare occurrence and has been reported only twice in the literature. We present a patient with primary hyperparathyroidism and medullary thyroid cancer with strong
Publikováno v:
Current diabetes reports. 19(11)
To highlight global advancements in diabetes technology and compare available technologies and device approval processes in the USA and Europe and their impact on safety and innovation. The last two decades have seen a rapid growth in diabetes techno
Autor:
Stephen K. Gruschkus, Elizabeth G. Grubbs, Steven I. Sherman, Steven G. Waguespack, Maria E. Cabanillas, Spandana Brown, Mark Zafereo, Mimi I. Hu, Ramona Dadu
Publikováno v:
Journal of Clinical Oncology. 38:6584-6584
6584 Background: Activating RAS mutations are recognized as important drivers in sporadic medullary thyroid cancer (sMTC), with a reported prevalence between 0-43%. However, few studies have looked at correlations between RAS-mutated sMTC and clinico
Publikováno v:
Methodist DeBakey cardiovascular journal. 13(2)
In patients with acromegaly, chronic excess of growth hormone (GH) and insulin-like growth factor-1 (IGF-1) leads to the development of acromegalic cardiomyopathy. Its main features are biventricular hypertrophy, diastolic dysfunction, and in later s
The parathyroid glands are critical to maintaining calcium homeostasis through actions of parathyroid hormone (PTH). Recent clinical and molecular research has shown that direct and indirect actions of PTH also affect the heart and vasculature throug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7fdc18882a58bda110a6b2f4facf117
https://europepmc.org/articles/PMC5512678/
https://europepmc.org/articles/PMC5512678/
Autor:
Laila Tabatabai, Spandana Brown
Publikováno v:
Endocrine Practice. 24:85-86
Publikováno v:
Endocrine Practice. 25:30
Publikováno v:
Endocrine Practice. 25:64
Publikováno v:
Methodist DeBakey Cardiovascular Journal. 14:257
Type 2 diabetes negatively impacts heart failure outcomes. Insulin resistance, central adiposity, dyslipidemia, and altered cellular substrate metabolism each have a mechanistic role. Management strategies focused solely on glycemic control have had